News
News

The latest updates from AFAR.

Grantee in the News: AFAR Postdoctoral Fellow Sofiya Milman Finds Common ‘Anti-Aging’ Treatment May Shorten Life

Mar 27
2014

Grantee in the News: AFAR Postdoctoral Fellow Sofiya Milman Finds Common ‘Anti-Aging’ Treatment May Shorten Life View MoreBACK

On March 27, 2014 LiveScience spotlighted 2012 Glenn/AFAR Postdoctoral Fellow Dr. Sofiya Milman’s study showing that injects of Human Growth Hormones (HGH), a commercial advertised “anti-aging” treatment, may have negative effects on longevity.  


Dr. Milman’s investigation found that people over 90 with naturally below average levels of HGH had a much greater chance of living to 100 than individuals with higher levels of the hormone. 


After a 1990s study showed that HGH injects increased muscle mass and bone density, and decreased body fat, the treatment was touted as an anti-aging cure.  This claim was never scientifically substantiated, and Dr. Milman’s research shows that treatment may actually cause detrimental longevity effects.


Dr. Sofiya Milman is an Assistant Professor at the Albert Einstein College of Medicine at Yeshiva University.


Learn more about the Glenn/AFAR Postdoctoral Fellow program here and for more on the biology of aging, check out a range of resources at InfoAging.org.





View MoreBACK TO TOP